<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Epigenetics</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0CEC6E19-2999-49FF-95D0-6A682CEB301E"><gtr:id>0CEC6E19-2999-49FF-95D0-6A682CEB301E</gtr:id><gtr:firstName>Wolf</gtr:firstName><gtr:surname>Reik</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B1A70213-E8A4-408D-BDB7-C7632933C989"><gtr:id>B1A70213-E8A4-408D-BDB7-C7632933C989</gtr:id><gtr:firstName>Myriam</gtr:firstName><gtr:surname>Hemberger</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0400154"><gtr:id>18E7A8B9-6BCB-46E0-8291-650C0150C3F7</gtr:id><gtr:title>Imprinting mechanisms in extraembryonic tissues</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0400154</gtr:grantReference><gtr:abstractText>An important part of gene regulation during development involves so-called epigenetic marks. These are chemical additions (eg methyl groups) to the DNA or the chromatin (the histone proteins) and instruct genes to be active or inactive. There is increasing evidence that faults in these epigenetic marks can lead to diseases in humans, particularly those affecting growth or behaviour. Recently it has been realised that defects in cloned animals and some rare diseases that occur in children born from IVF, can be explained by defective epigenetic marks. In this application, we describe work on a new epigenetic mechanism based on attachment of methyl groups to histones, rather than DNA. It is possible that the histone marks are less stable than the ones in DNA, and this could be relevant to the defects that occur in disease.</gtr:abstractText><gtr:technicalSummary>DNA methylation is thought to be the major mechanism of genomic imprinting. In mouse embryos lacking the maintenance methyltransferase Dnmt1, imprinting of all genes studied is disrupted. However we have recently found that imprinting of several genes in an imprinting cluster (on distal chromosome 7) is maintained faithfully in Dnmt1- mutants in extraembryonic tissues (placenta). Deletion of an imprinting control region which produces a non-coding antisense transcript (IC2), by contrast, results in loss of silencing. We find that in the placenta the silent genes are marked by repressive histone tail modifications, which are disrupted by IC2 deletion. Thus imprinting in extraembryonic tissues seems to involve epigenetic marks other than DNA methylation. We will determine the developmental sequence of establishment of these marks and imprinted expression of the genes, in relation to antisense RNA expression, using a conditional mutant of IC2. Trans-acting factors such as the polycomb gene Eed and G9a will be investigated. The discovery and characterization of a new imprinting mechanism will provide exciting insights into specific diseases and perhaps the association between epigenetic disorders and IVF , as well as cloning and cell plasticity.</gtr:technicalSummary><gtr:fund><gtr:end>2008-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>344492</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration with Peter Fraser's lab</gtr:description><gtr:id>0EBC6F06-D904-4141-AAFC-53DFC912F0CF</gtr:id><gtr:impact>New MRC grant (G0700760). See under that entry for publications</gtr:impact><gtr:outcomeId>FF7AF9BA8E6-1</gtr:outcomeId><gtr:partnerContribution>Techniques and reagents</gtr:partnerContribution><gtr:piContribution>Exchange of techniques and reagents</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>775000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant (G0700760)</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>192D0448-CA0B-45A6-B6AE-BE16F627B1FD</gtr:id><gtr:outcomeId>40A9D8CCB170</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Improved diagnosis of BWS patients</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>AB09A57E-7847-40EF-9F14-0F9295B07388</gtr:id><gtr:impact>Based on molecular pathological findings in Beckwith-Wiedemann syndrome patients refined diagnosis especially with reference to tumour risk is now possible with our clinical collaborator Professor Eamonn Maher</gtr:impact><gtr:outcomeId>3FAEB7645B0</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>0CABCEA4-5D00-4287-81E7-EEBAA72C217C</gtr:id><gtr:title>Imprinted genes, placental development and fetal growth.</gtr:title><gtr:parentPublicationTitle>Hormone research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244656f9a88033d35dbf5c570cf786fb"><gtr:id>244656f9a88033d35dbf5c570cf786fb</gtr:id><gtr:otherNames>Fowden AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0301-0163</gtr:issn><gtr:outcomeId>B480DF3F72D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>150781C1-BCCE-40F8-8D59-86A70EDC8E6B</gtr:id><gtr:title>A developmental window of opportunity for imprinted gene silencing mediated by DNA methylation and the Kcnq1ot1 noncoding RNA.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cd1c5958b8bca60c6b3b971e79f04a2"><gtr:id>1cd1c5958b8bca60c6b3b971e79f04a2</gtr:id><gtr:otherNames>Green K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>C20E5ED2B37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FC6FC29-C3CC-4E4E-BE28-6D67651ECD5A</gtr:id><gtr:title>Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32242a6e4d3e072bee76db2a9c2673d3"><gtr:id>32242a6e4d3e072bee76db2a9c2673d3</gtr:id><gtr:otherNames>Smits G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>71395124606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D6F3D14-9FA9-4866-B01F-8488DE5EF0B2</gtr:id><gtr:title>Non-coding transcripts in the H19 imprinting control region mediate gene silencing in transgenic Drosophila.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2afc637afdf8ad27cad07425bc3d448"><gtr:id>d2afc637afdf8ad27cad07425bc3d448</gtr:id><gtr:otherNames>Schoenfelder S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>D76527F7DFE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4758763E-6444-4D12-9B25-126F9C1262C5</gtr:id><gtr:title>CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbee45a2f18fcac27f7709bdbf71ac87"><gtr:id>bbee45a2f18fcac27f7709bdbf71ac87</gtr:id><gtr:otherNames>Kurukuti S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>3B94A5CEB55</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE29CD50-F9B2-4620-B8D8-8DFBDE170906</gtr:id><gtr:title>Epigenetic dynamics of the Kcnq1 imprinted domain in the early embryo.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c0c491542560302154b1fa50fa51bf"><gtr:id>89c0c491542560302154b1fa50fa51bf</gtr:id><gtr:otherNames>Lewis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>CE2D37B184E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0986A0F2-07D9-4873-A1DB-27B0C065370B</gtr:id><gtr:title>Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2c881100e23b0e46b19412580ca110c"><gtr:id>f2c881100e23b0e46b19412580ca110c</gtr:id><gtr:otherNames>Ng RK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>A716E96EF31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0143E17B-FD24-4430-88D5-80F7AA6D8449</gtr:id><gtr:title>How imprinting centres work.</gtr:title><gtr:parentPublicationTitle>Cytogenetic and genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c0c491542560302154b1fa50fa51bf"><gtr:id>89c0c491542560302154b1fa50fa51bf</gtr:id><gtr:otherNames>Lewis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1424-8581</gtr:issn><gtr:outcomeId>667CE170251</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0400154</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>